Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Forgot password?
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Quick Order
Products
Antibodies
ELISA and Assay Kits
Research Areas
Infectious Disease
Resources
Purchasing
Reference Material
Contact Us
Locations
Orders Processing,
Shipping & Receiving,
Warehouse
2 Shaker Rd Suites
B001/B101
Shirley, MA 01464
Production Lab
Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036
Telephone Numbers
Tel: +1 (206) 374-1102
Fax: +1 (206) 577-4565
Contact Us
Additional Contact Details
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Forgot password?
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Quick Order
| Catalog Number | Size | Price |
|---|---|---|
| LS-G138836-10 | 10 µg | $262 |
| LS-G138836-50 | 50 µg | $339 |
Human TNFRSF14 / CD270 / HVEM Protein (Recombinant mFc, C-terminus) (Pro37-Val202) - LS-G138836
Human TNFRSF14 / CD270 / HVEM Protein (Recombinant mFc, C-terminus) (Pro37-Val202) - LS-G138836
Description:
TNFRSF14 / CD270 / HVEM Protein LS-G138836 is a Recombinant Human TNFRSF14 / CD270 / HVEM produced in Mammalian Cells Pro37-Val202 with mFc, C-terminus tag(s). It is low in endotoxin; Less than 1.0 EU/µg protein (determined by LAL method). For Research Use Only
Toll Free North America
206-374-1102
206-374-1102For Research Use Only
Overview
Description:
TNFRSF14 / CD270 / HVEM Protein LS-G138836 is a Recombinant Human TNFRSF14 / CD270 / HVEM produced in Mammalian Cells Pro37-Val202 with mFc, C-terminus tag(s). It is low in endotoxin; Less than 1.0 EU/µg protein (determined by LAL method). For Research Use Only
Specifications
Type
Recombinant Protein
Target
TNFRSF14 / CD270 / HVEM
Synonyms
TNFRSF14 | CD270 | CD270 antigen | CD40-like protein | Herpesvirus entry mediator | Herpesvirus entry mediator A | HVEM | LIGHTR | Herpes virus entry mediator A | TR2 | ATAR | HVEA
Species
Human
Modifications
Unmodified
Conjugations
Unconjugated
Tag
mFc, C-terminus
Region
Pro37-Val202
Predicted Molecular Weight
44.1 kDa
Expression System
Mammalian Cells
Source Species
Mammal
Purification
Greater than 95% by SDS-PAGE
Usage Summary
Recombinant Human HVEM is produced by our Mammalian expression system and the target gene encoding Pro37-Val202 is expressed with a mFc tag at the C-terminus.
Bio-Activity
Not Tested
Endotoxin
Less than 1.0 EU/µg protein (determined by LAL method).
Presentation
Lyophilized from a sterile solution in PBS, pH 7.4, 150 mM NaCl
Storage
Store lyophilized at room temperature for up to 3 weeks, or at -20°C or below. Aliquot and store reconstituted at 4°C-7°C for up to 1 week, or at -20°C or below for up to 3 months. Avoid freeze/thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
About TNFRSF14 / CD270 / HVEM
Publications (0)
Customer Reviews (0)
Popular TNFRSF14 / CD270 / HVEM Proteins
Source:
E. coli
Tag:
His
Source:
Mammal
Tag:
His,C-terminus
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 5/7/2024
Date Requested: 5/7/2024
